Julie H. Oestreich

2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations

Victor A. Ferraris, Sibu P. Saha, Julie H. Oestreich et al. · The Annals of Thoracic Surgery · 2012 · 288 citations

Cardiac Surgery, Thrombosis, Cardiac Anaesthesia +15

Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist

Wendell S. Akers, Jennifer J. Oh, Julie H. Oestreich et al. · The Journal of Clinical Pharmacology · 2009 · 168 citations

Thrombopoiesis, Thrombosis, Pharmacological Study +13

Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect

Steven R. Steinhubl, Jennifer J. Oh, Julie H. Oestreich et al. · Thrombosis Research · 2007 · 165 citations

Pharmacology, Clinical Pharmacology, Competitive Effect +4

Elinogrel, a reversible P2Y12 receptor antagonist for the treatment of acute coronary syndrome and prevention of secondary thrombotic events.

Julie H. Oestreich · PubMed · 2010 · 31 citations

Cardiovascular Pharmacology, Pharmacotherapy, Single-dose Elinogrel +18

SCH-530348, a thrombin receptor (PAR-1) antagonist for the prevention and treatment of atherothrombosis.

Julie H. Oestreich · PubMed · 2009 · 30 citations

Pharmacotherapy, Platelet Aggregation, Molecular Pharmacology +16